Willow Life Sciences, Inc. — Form D
Willow Life Sciences, Inc. of ALLSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-11-06. The offering totals $4.0M, of which $4.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2025-11-06
- Form: D
- Accession: 0002083161-25-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $4.0M
- Investors: 19
- Date of first sale: 2025-05-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-563278
Issuer
- Name: Willow Life Sciences, Inc.
- CIK: 0002083161
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 127 WESTERN AVENUE, ALLSTON, MA, 02134
- Phone: (765) 212-9972
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Mariia Grebenshchikova | Director | Allston, MA |
| Morgan Moncada | Director | Allston, MA |
| Catherine Tadina | Director | Allston, MA |
| Morgan Moncada | Executive Officer | Allston, MA |
More